SIPPICAN CAPITAL ADVISORS – Takeda Pharmaceutical Company Limited Transaction History
SIPPICAN CAPITAL ADVISORS portfolio value:
$1.13M
portfolio value
SIPPICAN CAPITAL ADVISORS quarter portfolio value change:
-7.62%
quarter
Takeda Pharmaceutical Company Limited 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.64% | 1.41K shares | -74K | $12.97 | 87.46K |
| Q2 2022 | share | Increase | +6.90% | 5.55K shares | 55K | $14.04 | 86.04K |
| Q1 2022 | share | Increase | +15.73% | 10.94K shares | 205K | $14.32 | 80.49K |
| Q4 2021 | share | Increase | +60.55% | 26.23K shares | 238K | $13.58 | 69.55K |
| Q3 2021 | share | Increase | +324.29% | 33.11K shares | 538K | $16.38 | 43.32K |
| Q2 2021 | share | Increase | 0.00% | 10.21K shares | 172K | $16.83 | 10.21K |